![Tim Matthew Bernard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tim Matthew Bernard
Directeur/Bestuurslid bij Cellexus International Ltd.
Profiel
Tim Matthew Bernard is currently a Director at Cellexus International Ltd.
Prior to this, he was a Director at Medix Biochemica Oy Ab from 2016 to 2018.
Actieve functies van Tim Matthew Bernard
Bedrijven | Functie | Begin |
---|---|---|
Cellexus International Ltd.
![]() Cellexus International Ltd. BiotechnologyHealth Technology Cellexus International Ltd. offers a personalized solution for each client with their revolutionary, market-leading single-use airlift bioreactor systems. The company is based in Forfar, UK. The British company's technology is designed to improve cell culture and fermentation processes, and their CellMaker range has been proven successful for cell culture, microbial fermentations, and phage applications. The company was founded in 2017 by Kevin A. Auton, and Gavin William Valentine Hands has been the CEO of the company since 2017. | Directeur/Bestuurslid | 29-06-2021 |
Eerdere bekende functies van Tim Matthew Bernard
Bedrijven | Functie | Einde |
---|---|---|
Medix Biochemica Oy Ab
![]() Medix Biochemica Oy Ab Medical SpecialtiesHealth Technology Medix Biochemica Oy Ab develops, produces, and markets monoclonal antibodies, antibody services, and recombinant antigens for in vitro diagnostics industry. It also provides rapid tests for human healthcare. The company was founded in 1985 and is headquartered in Espoo, Finland. | Directeur/Bestuurslid | 01-01-2018 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Medix Biochemica Oy Ab
![]() Medix Biochemica Oy Ab Medical SpecialtiesHealth Technology Medix Biochemica Oy Ab develops, produces, and markets monoclonal antibodies, antibody services, and recombinant antigens for in vitro diagnostics industry. It also provides rapid tests for human healthcare. The company was founded in 1985 and is headquartered in Espoo, Finland. | Health Technology |
Cellexus International Ltd.
![]() Cellexus International Ltd. BiotechnologyHealth Technology Cellexus International Ltd. offers a personalized solution for each client with their revolutionary, market-leading single-use airlift bioreactor systems. The company is based in Forfar, UK. The British company's technology is designed to improve cell culture and fermentation processes, and their CellMaker range has been proven successful for cell culture, microbial fermentations, and phage applications. The company was founded in 2017 by Kevin A. Auton, and Gavin William Valentine Hands has been the CEO of the company since 2017. | Health Technology |